Vida Ventures
Overview
Vida Ventures is a next-generation life sciences investment firm comprised of scientists, physicians, entrepreneurs and investors who are passionate about building and funding breakthroughs in biomedicine . Vida's mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients . Vida focuses on identifying groundbreaking science and building innovative companies that lead to new areas of drug discovery and development .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Adcendo | Apr 2026 | Series C | Co-investor |
| Poplar Therapeutics | Mar 2026 | Series A Extension | Co-investor |
| Poplar Therapeutics | Jan 2026 | Series A | Lead |
| Protego Biopharma | Dec 2025 | Series B | Co-investor |
| Soufflé Therapeutics | Oct 2025 | Series A | Co-investor |
Key People
Arie Belldegrun
Co-Founder And Sr. Managing Partner
Fred Cohen
Co-Founder And Sr. Managing Director
Stefan Vitorovic
Co-Founder Managing Director
Gena Zoe
Partner
Kate Bechtold
Senior Director, Investor Relations
Alex Loftis
Principal
Mark Springel
Principal
Christopher Weyrer
Venture Capital - Life Science
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
